Search
for
Sort by
Research 121–150 of 228
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Chemotherapy-induced alopecia
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Back to the Roots—An Overview of the Chemical Composition and Bioactivity of Selected Root-Essential Oils
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Significance of stress keratin expression in normal and diseased epithelia
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Maintaining Hair Inductivity in Human Dermal Papilla Cells: A Review of Effective Methods
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Tideglusib promotes wound healing in aged skin by activating PI3K/Akt pathway
- Recent advances in 3D bioprinting of tissues and organs for transplantation and drug screening
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications
- Poster Presentations
- Current Biomedical Applications of 3D-Printed Hydrogels
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation